Comparison of Different Spectral Domain Optical Coherence Tomography Scanning Areas for Glaucoma Diagnosis
To access this article, please choose from the options below
Manuscript no. 2009-1274.
Financial Disclosure(s): Linda M. Zangwill – Grant/Financial Support - Heidelberg Engineering, Carl Zeiss, OptovueRobert N. Weinreb – Consultant, Grant/Financial Support - Optovue, Topcon, Carl Zeiss; Grant/Financial Support - Heidelberg EngineeringPamela A. Sample – Grant/Financial Support - Carl Zeiss, Heidelberg Engineering, Welch AllynFelipe A. Medeiros – Consultant, Grant/Financial Support - Carl Zeiss; Lecture Fees - Heidelberg Engineering
Supported in part by NEI EY08208 (PAS), NEI EY11008 (LMZ), Participant retention incentive grants in the form of glaucoma medication at no cost (Alcon Laboratories Inc., Allergan, Pfizer Inc., SANTEN Inc.).
PII: S0161-6420(10)00060-6
doi:10.1016/j.ophtha.2010.01.031
© 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

